机译:开始降压和降脂治疗的患者处方负担与药物依从性之间的关联
Engelberg Center for Health Care Reform, The Brookings Institution, Washington, DC, and Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia;
Health Economics and Outcomes Research, IMS Health, 300 North Washington Street, Suite 303, Falls Church, VA 22046;
Health Economics and Outcomes Research, IMS Health;
Customer Business Unit, Pfizer Inc., New York, NY;
Bridgewater, NJ;
Health Care Management, and Economics, School of Medicine and Wharton School, University of Pennsylvania, Philadelphia;
antilipemic agents; compliance; hyperlipidemia; hypertension; hy-potensive agents; managed care systems; patients;
机译:经济负担的影响,由处方共同支付,对较旧的公开投保人群的抗高血压药物遵守
机译:在冠心病事件后开始治疗的患者中,低降压药物依从性可预测他汀类药物停用和低他汀类药物依从性。
机译:降低2型糖尿病和风险相关LDL胆固醇患者的降脂药物处方:瑞典国家糖尿病登记系统对指南依从性的全国性研究
机译:中国广东省2型糖尿病患者药物粘附与治疗满意度与治疗的关联
机译:糖尿病患者对患者服药障碍的感知对药物依从性的作用:Murage-Marrero-Monahan药物障碍量表(4M量表),与药物障碍相关的患者特征以及药物障碍和心血管疾病(CVD)的风险。
机译:处方共付产生的财务负担对老年公共保险人群中降压药物依从性的影响
机译:具有抗糖尿病,抗高血压和降脂药物的PCV65患者坚持治疗:对2型糖尿病退伍军人的评估
机译:感染HIV的患者降脂和降压药物的疗效比较。包容性日期:09/29/10 - 09/29/12。